Vilor-F 50 Inhaler 120 MDI
₹674.1*
MRP ₹749
10% off
₹637*
MRP ₹749
15% CB
₹112 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Vilor-F 50 Inhaler 120 MDI belongs to the class of medicines called respiratory stimulants. It treats asthma and chronic obstructive pulmonary diseases (COPD). Asthma is a severe long-term health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. Symptoms may include shortness of breath or wheezing (whistling sound while breathing). COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. Vilor-F 50 Inhaler 120 MDI helps reduce symptoms of asthma and COPD.
Vilor-F 50 Inhaler 120 MDI contains Fluticasone Furoate (an inhaled corticosteroid) and Vilanterol (long-acting beta-agonists—LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate inhibits the release of certain chemicals in the body that cause inflammatory reactions, thus providing relief from sneezing, shortness of breath, or wheezing.
Vilor-F 50 Inhaler 120 MDI is for inhalation use only. It should be used as your doctor advises. Your doctor will recommend the dose and duration of medicine based on your condition. Vilor-F 50 Inhaler 120 MDI may cause specific side effects such as sore throat, sneezing, headache, cough, low fever, chest tightness, stuffy nose, a fungal infection in the mouth, nausea, stomach upset, dizziness, nervousness, or vomiting. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Vilor-F 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. This medicine should be avoided in patients with life-threatening conditions of asthma or COPD. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, or kidney/liver problems or take any immunosuppressant medicines before taking this medicine. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Vilor-F 50 Inhaler 120 MDI. If you experience severe difficulty breathing or wheezing while using Vilor-F 50 Inhaler 120 MDI, please consult your doctor immediately so that alternative medicine may be prescribed. Vilor-F 50 Inhaler 120 MDI is not recommended for children below 12 years of age.
Vilor-F 50 Inhaler 120 MDI is a combination medicine that contains Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Vilor-F 50 Inhaler 120 MDI also helps reduce exacerbations in patients suffering from COPD.
Vilor-F 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, kidney/liver disease, or if you are taking any immunosuppressant medicines, as it can lead to serious infections. Regular monitoring of potassium levels and blood sugar levels is recommended while taking Vilor-F 50 Inhaler 120 MDI. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Vilor-F 50 Inhaler 120 MDI. Sometimes, this medicine may worsen asthma symptoms in some patients. If you experience severe difficulty in breathing or wheezing, please consult a doctor immediately so that alternative medicine may be prescribed. Vilor-F 50 Inhaler 120 MDI is not recommended for children below 12 years of age.
Drug-Drug Interactions: Vilor-F 50 Inhaler 120 MDI may interact with bronchodilators (salbutamol, aminophylline, theophylline), steroids (budesonide, prednisone, mometasone, beclomethasone), heart-related medicines (sotalol, digoxin, disopyramide, procainamide, quinidine), drugs used to lower high blood pressure (atenolol, metoprolol, propranolol), medicines to induce labour (oxytocin), antithyroid agent (levothyroxine), antidepressants (imipramine, amitriptyline, isocarboxazid, phenelzine), antifungals (itraconazole, ketoconazole), HIV medicines (atazanavir, ritonavir, nelfinavir, indinavir, cobicistat, saquinavir) and antiparkinson drug (levodopa).
Drug-Food Interactions: Vilor-F 50 Inhaler 120 MDI may interact with grapefruit and grapefruit juice. Therefore, avoid intake of grapefruit or its juice with Vilor-F 50 Inhaler 120 MDI as it may lead to severe adverse effects.
Drug-Disease Interactions: If you have high blood pressure, diabetes, chest or lung infection, hyperthyroidism (overactive thyroid), hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, heart, liver or adrenal gland problems, inform your doctor before taking Vilor-F 50 Inhaler 120 MDI.
Asthma: Asthma is a long-term serious health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. The symptoms may include chest tightness, wheezing (whistling sound while breathing), shortness of breath, and cough, especially at night. The treatment for asthma includes medication, breathing exercises, and self-care.
Chronic obstructive pulmonary disease (COPD): COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. The symptoms include chronic cough, shortness of breath, or wheezing (whistle sound while breathing). It can occur due to smoking tobacco, and long-term exposure to fumes and chemicals may lead to COPD.
Alcohol
Consult your doctor
It is unknown whether Vilor-F 50 Inhaler 120 MDI will interact with alcohol. It is advised to avoid or limit consumption of alcohol while on treatment with this medicine.
Pregnancy
Caution
Limited data is available on the effect of Vilor-F 50 Inhaler 120 MDI in pregnancy. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking Vilor-F 50 Inhaler 120 MDI. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
It is unknown whether Vilor-F 50 Inhaler 120 MDI passes through breastmilk or not. Hence, if you are breastfeeding, inform your doctor before taking Vilor-F 50 Inhaler 120 MDI. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Not applicable
Vilor-F 50 Inhaler 120 MDI usually does not affect your ability to drive or operate machinery.
Liver
Caution
Use Vilor-F 50 Inhaler 120 MDI with caution, especially if you have a history of liver disease. Your doctor will weigh the benefits and risks before prescribing this medicine.
Kidney
Caution
Use Vilor-F 50 Inhaler 120 MDI with caution, especially if you have a history of kidney disease. Your doctor will weigh the benefits and risks before prescribing this medicine.
Children
Unsafe
Vilor-F 50 Inhaler 120 MDI is not recommended for children below 18 years as the safety and effectiveness were not established. Please consult your doctor.
Country of origin
Manufacturer/Marketer address
Customers Also Bought